Managed Care Liaison (MCL) / Health Economics Field Lead # 4545

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. GRAIL is headquartered in the bay area of California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com This is a US field-based position responsible for communicating and refining health economic and outcomes research (HEOR) evidence that supports payer engagement activities across GRAIL’s diagnostic portfolio. This is accomplished through high-quality, non-promotional scientific exchange, including payer-focused education, evidence discussions, and responses to unsolicited medical and scientific inquiries. In this position, you will partner closely with the Market Access Payer Engagement and Government Affairs teams, serving as a scientific and economic subject matter expert (SME) when payer-facing interactions require deep HEOR expertise. The role combines scientific and clinical fluency with strong understanding of payer evidence expectations, reimbursement considerations, and value communication. This role partners closely with Medical Affairs, Market Access, Government Affairs, and Commercial teams and plays a critical role in shaping payer value narratives and supporting evidence-based messaging. This is a remote - field based position with up to 35% of travel.